Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study shows COVID booster shots work

A new study investigates uses seven different COVID-19 vaccines as the third dose to boost immunity in vulnerable patients.

6 Dec 2021

SARS-CoV-2 Delta saliva viral load 15 times that of the wild type

Researchers hypothesize that a higher viral load of SARS-CoV-2 Delta variant in saliva contributes to its high transmissibility.

6 Dec 2021

Hospitalization trends and associated factors for COVID in 2.3 million adults in England

Researchers performed a retrospective cohort study to determine risk factors for hospitalization and mortality rates over time among COVID-19 patients.

6 Dec 2021

New marker could lead to better diagnoses of Covid-19

Biomedical scientists at LMU have found a new marker in the blood of Covid-19 patients. It furnishes insights into the course and development of the disease and could lead to better diagnoses.

6 Dec 2021

SARS-CoV-2 virus-like particles elicit potent neutralizing antibody response in variant challenge

Researchers develop a virus-like particle for SARS-CoV-2 based on the co-expression of the spike, membrane, and envelope structural proteins.

6 Dec 2021

Using soft X-ray tomography for 3D imaging of cell structures in few minutes

Viral pathogens like the SARS-CoV-2 coronavirus change the interior structure of the cells they infect. These changes occur at the level of individual cell components – the organelles – and can provide information on how viral diseases develop.

6 Dec 2021

Most young people improve quickly from COVID-19 vaccine-related myocarditis

Most young people under the age of 21 who developed suspected COVID-19 vaccine-related heart muscle inflammation known as myocarditis had mild symptoms that improved quickly, according to new research published today in the American Heart Association's flagship journal Circulation.

6 Dec 2021

Inequalities of the US COVID-19 vaccination drive

The percentage of individuals with at least one dose of a COVID-19 vaccine, by communities, were collected from eight cities to determine US vaccine inequality.

6 Dec 2021

Safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine

Researchers have presented the results of phase 1 and phase 2 clinical trials of a SARS-CoV-2 recombinant spike protein vaccine (Abdala).

6 Dec 2021

Colorimetric detection of SARS-CoV-2 viral RNA by an in vitro transcription/translation assay

This work has emphasized the clinical and translational potential of paper-based biosensors.

6 Dec 2021

SARS-CoV-2 immune memory in mRNA vaccine recipients

Researchers measured SARS-CoV-2–specific antibody, memory B cell, and memory T cell responses in a group of healthy subjects who generated primary immune responses to two doses of mRNA vaccine compared to a group of SARS-CoV-2–recovered vaccines.

6 Dec 2021

Forecasting outbreak of SARS-CoV-2 Omicron variant with Tajima's D

A new study argues that that rapid genomic sequence surveillance is absolutely crucial and Tajima D tests should be included to predict future COVID-19 outbreaks.

6 Dec 2021

Announcing the Winners of The Scientist’s Top 10 Innovations of 2021

Each year The Scientist seeks to highlight the latest and greatest tools, technologies, and techniques to hit the life science landscape.

From Resolve Biosciences 6 Dec 2021

Saliva samples show better sensitivity for early stages of COVID-19 detection

Study explores the advantages of saliva compared to MTS and recommends the use of saliva for large-scale screening of COVID-19, especially in pre-symptomatic patients.

6 Dec 2021

COVID-19-recovered patients at an increased risk of developing new-onset mental illness

Research suggests that patients who have recovered from COVID-19 were at an increased risk for developing new-onset mental illness.

6 Dec 2021

The link between cytokine storms and cardiovascular problems in COVID-19 patients

New findings may help doctors choose effective COVID-19 treatment regimens for patients with heart complications.

6 Dec 2021

Sino Biological Launches A Panel of Research Reagents for SARS-CoV-2 Omicron Variant (B.1.1.529)

Sino Biological, Inc. (https://www.sinobiological.com; SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus

From Sino Biological Inc. 6 Dec 2021

COVID-19 vaccines shown to reduce SARS-CoV-2 infection rate in cancer patients

A study recently published in the journal JAMA Oncology has stated that coronavirus disease 2019 (COVID-19) vaccines are more than 55% effective in reducing the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in cancer patients.

5 Dec 2021

UK's COVID-19 booster program accelerated, and people urged to get top-up jabs

People have been urged to get a coronavirus (COVID-19) booster vaccine to top-up their protection this winter as 20 million people in the UK are expected to have had their third jabs today (Sunday 5 December 2021).

5 Dec 2021

A new model linking SARS-CoV-2 viral load to infectiousness may guide further testing strategy

...

5 Dec 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study shows COVID booster shots work

SARS-CoV-2 Delta saliva viral load 15 times that of the wild type

Hospitalization trends and associated factors for COVID in 2.3 million adults in England

New marker could lead to better diagnoses of Covid-19

SARS-CoV-2 virus-like particles elicit potent neutralizing antibody response in variant challenge

Using soft X-ray tomography for 3D imaging of cell structures in few minutes

Most young people improve quickly from COVID-19 vaccine-related myocarditis

Inequalities of the US COVID-19 vaccination drive

Safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine

Colorimetric detection of SARS-CoV-2 viral RNA by an in vitro transcription/translation assay

SARS-CoV-2 immune memory in mRNA vaccine recipients

Forecasting outbreak of SARS-CoV-2 Omicron variant with Tajima's D

Announcing the Winners of The Scientist’s Top 10 Innovations of 2021

Saliva samples show better sensitivity for early stages of COVID-19 detection

COVID-19-recovered patients at an increased risk of developing new-onset mental illness

The link between cytokine storms and cardiovascular problems in COVID-19 patients

Sino Biological Launches A Panel of Research Reagents for SARS-CoV-2 Omicron Variant (B.1.1.529)

COVID-19 vaccines shown to reduce SARS-CoV-2 infection rate in cancer patients

UK's COVID-19 booster program accelerated, and people urged to get top-up jabs

A new model linking SARS-CoV-2 viral load to infectiousness may guide further testing strategy

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in